retatrutide parkinson's disease From metabolism to mind: The expanding role of the GLP-1 receptor in neurotherapeutics Retatrutide Delivers Significant Hemoglobin A1C
Description
doi: 10.1126/science.adn4128

Tirzepatide For weight loss, glucose control, and cardiometabolic benefits
High insulin levels can disrupt the ovaries usual production of hormones, which impacts ovulation and leads to irregular periods

Retatrutide activates three receptor pathways (GLP-1, GIP, glucagon) compared to semaglutide's one (GLP-1)
1 Irregular heartbeats Across Phase 2 and Phase 3 trials, irregular heartbeats were reported in 2 to 11% of people on retatrutide, compared with around 2% on placebo

At the same time, the clinical orientation of MGHs research communities appears to have diminished the recognition of Mojsovs essential contributions during the period she was there
